Urolithiasis: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (New page: In medicine, '''urolithiasis''' if the "formation of stones in any part of the urinary tract, usually in the kidney; urinary bladder; or the [[urete...) |
imported>Robert Badgett m (→Etiology/cause) |
||
Line 8: | Line 8: | ||
==Etiology/cause== | ==Etiology/cause== | ||
* Hypercalcuria - | * Hypercalcuria - >140 mg/gm of urine creatinine or >4 mg/kg of body weight | ||
* Hyperoxaluria - >40mg in 24 hour urine. May be primary or secondary to disorders such as inflammatory bowel disease | * Hyperoxaluria - >40mg in 24 hour urine. May be primary or secondary to disorders such as inflammatory bowel disease | ||
* | * Hypocitruria | ||
* Uric acid | * Uric acid | ||
* | * Struvite | ||
* | * Cysteine | ||
==Treatment== | ==Treatment== |
Revision as of 12:23, 1 May 2010
In medicine, urolithiasis if the "formation of stones in any part of the urinary tract, usually in the kidney; urinary bladder; or the ureter."[1]
Classification
Etiology/cause
- Hypercalcuria - >140 mg/gm of urine creatinine or >4 mg/kg of body weight
- Hyperoxaluria - >40mg in 24 hour urine. May be primary or secondary to disorders such as inflammatory bowel disease
- Hypocitruria
- Uric acid
- Struvite
- Cysteine
Treatment
Prevention
Chlorthalidone reduces recurrence of calcium oxalate stones.[2]
References
- ↑ Anonymous (2024), Urolithiasis (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Ettinger B, Citron JT, Livermore B, Dolman LI (1988). "Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not.". J Urol 139 (4): 679-84. PMID 3280829.